Artwork

Innhold levert av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Episode 8.1 Overuse of HCGs, Famous Studies in OB, and the History of Mag Sulfate

1:03:52
 
Del
 

Manage episode 428275645 series 3496984
Innhold levert av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In the season 8 premiere, we discuss over-utilization of serial quantitative HCGs. Then we discuss several famous or influential studies in obstetrics, including the WOMAN trial, the CLASP trial, the ARRIVE trial, MagPIE, and several more. Finally, we discuss the history of how magnesium sulfate came to be used in obstetrics.
00:00:02 Overuse of HCG

00:13:17 Aspirin for Preeclampsia Prevention Debate

00:18:51 Debate on the ARRIVE Trial

00:29:10 MagPIE

00:39:05 Fetal Fibronectin Trials

00:44:53 Induction at 41 Weeks Discussion

00:55:16 History of Magnesium Use in Obstetrics

Follow us on Instagram @thinkingaboutobgyn.

  continue reading

Kapitler

1. Episode 8.1 Overuse of HCGs, Famous Studies in OB, and the History of Mag Sulfate (00:00:00)

2. Overuse of HCG (00:00:02)

3. Aspirin for Preeclampsia Prevention Debate (00:13:17)

4. Debate on the ARRIVE Trial (00:18:51)

5. MagPIE (00:29:10)

6. Fetal Fibronectin Trials (00:39:05)

7. Induction at 41 Weeks Discussion (00:44:53)

8. History of Magnesium Use in Obstetrics (00:55:16)

96 episoder

Artwork
iconDel
 
Manage episode 428275645 series 3496984
Innhold levert av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Antonia Roberts and Howard Herrell, Antonia Roberts, and Howard Herrell eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

In the season 8 premiere, we discuss over-utilization of serial quantitative HCGs. Then we discuss several famous or influential studies in obstetrics, including the WOMAN trial, the CLASP trial, the ARRIVE trial, MagPIE, and several more. Finally, we discuss the history of how magnesium sulfate came to be used in obstetrics.
00:00:02 Overuse of HCG

00:13:17 Aspirin for Preeclampsia Prevention Debate

00:18:51 Debate on the ARRIVE Trial

00:29:10 MagPIE

00:39:05 Fetal Fibronectin Trials

00:44:53 Induction at 41 Weeks Discussion

00:55:16 History of Magnesium Use in Obstetrics

Follow us on Instagram @thinkingaboutobgyn.

  continue reading

Kapitler

1. Episode 8.1 Overuse of HCGs, Famous Studies in OB, and the History of Mag Sulfate (00:00:00)

2. Overuse of HCG (00:00:02)

3. Aspirin for Preeclampsia Prevention Debate (00:13:17)

4. Debate on the ARRIVE Trial (00:18:51)

5. MagPIE (00:29:10)

6. Fetal Fibronectin Trials (00:39:05)

7. Induction at 41 Weeks Discussion (00:44:53)

8. History of Magnesium Use in Obstetrics (00:55:16)

96 episoder

Todos os episódios

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett